Vertex Falls After FDA Halts Diabetes Study in Surprise Move

Vertex Falls After FDA Halts Diabetes Study in Surprise Move

Source: 
Yahoo/Bloomberg
snippet: 

Vertex Pharmaceuticals Inc. tumbled after U.S. regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.